December 1, 2015
Velneva’s Clostridium difficile vaccine Candidate meets Phase II trial target
Velneva’s Clostridium difficile vaccine Candidate meets Phase II trial target
Pharmaceuticals, Biotechnology and Life Sciences
Category: Europe
November 30, 2015
European Commission approves Horizon’s Ravicti for treating Urea Cycle Disorders
Horizon Pharma and its affiliate, Horizon Therapeutics, has gotten the European Commission’s (EC’s) approval for Ravicti – glycerol phenylbutyrate – Oral Liquid for use as an adjunctive therapy for chronic management patients with six subtypes of Urea Cycle Disorders (UCDs).
November 30, 2015
PureTech Health launches Scientific Advisory Board
Boston-based PureTech Health plc has launched a Scientific Advisory Board (SAB) of distinguished scientists and physicians, and the expansion of PureTech’s senior team.
November 27, 2015
Exclusive: Lazard works with Sanofi on $12.7 billion animal health unit deal – sources
By Pamela Barbaglia, Olivia Oran and Arno Schuetze LONDON/NEW YORK/FRANKFURT (Reuters) – Investment bank Lazard is working with Sanofi’s management…
November 27, 2015
Two-decade Pfizer mission pays off for Gueggenheim’s deal king
Two-decade Pfizer mission pays off for Gueggenheim’s deal king
November 27, 2015
EU opens door for Impax’s Parkinson’s treating oral capsule Numient
Impax Laboratories has been granted by the European Commission (EC) authorization to market its Numient oral capsule formulation for the symptomatic treatment of adult patients with Parkinson’s disease.
November 27, 2015
No revenues for Kiadis Pharma in the first 9 months 2015
Kiadis Pharma did not generate any revenues in the first nine months of 2015, the company said Friday.
November 27, 2015
WHO records highest-ever number of new HIV cases in its European Region
The World Health Organisation (WHO) said on Thursday that in 2014 it had recorded the highest number of new HIV cases in its European Region, which also includes Central Asia, since the start of reporting in the 1980s.
November 26, 2015
Sinclair IS Pharma going aesthetic
Sinclair IS Pharma plc will sell its non-aesthetics business to Alliance Pharma plc for £132m
November 26, 2015
NICE recommends drugs to treat 4 different medical conditions
The National Institute for Health and Care Excellence (NICE) has published its final recommendations on whether six different drug treatments…